干针治疗紧张型头痛:对干预程序,肌肉点和结果的范围审查
Ana Bravo-Vazquez1, Ernesto Anarte-Lazo2, Cleofas Rodriguez-Blanco3
1Doctoral Program in Health Sciences, University of Seville, 41009 Seville, Spain.
Journal of clinical medicine
|August 14, 2025
概括
干针 (DN) 通过准特定的肌肉,如骨和骨,有效地管理紧张型头痛 (TTH). 虽然安全和有益,但为了在TTH管理中获得一致的结果,需要对DN协议和诊断标准进行标准化.
科学领域:
- 神经学 神经学
- 疼痛管理 疼痛管理
- 物理疗法物理治疗
背景情况:
- 紧张型头痛 (TTH) 是最常见的初级头痛疾病.
- 它的确切原因尚不清楚,但与头部和部肌肉中的肌肌触发点 (MTP) 有关.
- 干针 (DN) 是一种有希望的非药物治疗疼痛的方法,但其在TTH中的特定应用需要审查.
研究的目的:
- 系统地审查干针干燥干燥干燥干燥干燥干燥干燥干燥干燥干燥干燥干燥干燥干燥干燥干燥干燥干燥干燥干燥干燥干燥干燥干燥干燥干燥干燥干燥干燥干燥干燥干燥干燥干燥干燥干燥干燥干燥干燥干燥干燥干燥干燥干燥干燥干燥干燥干燥干燥干燥干燥干燥干燥干燥干燥干燥干燥干燥干燥干燥干燥干燥干燥干燥干燥干燥干燥干燥干燥干燥干燥干燥干燥干燥干燥干燥干燥干燥干燥干燥干燥干燥干燥干燥干燥干燥干燥干燥干燥干燥干燥干燥干燥干燥干燥干燥干燥干燥干燥干燥干燥干燥干燥干燥干燥干燥干燥干燥干燥干燥干燥干燥干燥干燥干燥干燥干燥干燥干燥干燥干燥干燥干燥干燥干燥
- 为了识别常见的目标肌肉和用于TTH的DN的技术.
- 评估报告的结果和DN在TTH管理中的安全性.
主要方法:
- 进行了一个范围审查,搜索主要数据库 (PubMed,Embase,Scopus,Web of Science).
- 纳入标准集中在评估TTH成人DN的研究上,详细介绍目标肌肉,诊断标准和技术方面.
- 选择和分析了七项研究,主要是随机对照试验.
主要成果:
- 该审查包括309名参与者,其中形肌和形肌肌是最常见的目标.
- 肌关节触发点主要通过手动触摸识别,具有不同的诊断标准.
- 所有研究报告了积极的结果,包括改善头痛症状,并指出DN的安全性没有严重的不良事件.
结论:
- 干针治疗对TTH管理有前途,特别是在准时肌和梯形肌肌时.
- 跨研究的DN协议和诊断标准的异质性限制了直接比较,需要标准化.
- 建议进行进一步的研究,以建立TTH的最佳DN协议,增强临床实践和患者的结果.
相关概念视频
Skeletal Muscle Relaxants: Therapeutic Uses
616
Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx...
616
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
758
Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.
The binding of dantrolene to the RYR1...
The binding of dantrolene to the RYR1...
758
Peripherally and Centrally Acting Muscle Relaxants: A Comparison
3.7K
Skeletal muscle relaxants can target the central nervous system [CNS] to reduce muscle tension or act directly at the neuromuscular junction to induce temporary paralysis. These two classes of muscle relaxants are called centrally acting muscle relaxants and peripherally acting muscle relaxants. They differ in their action, mechanism, administration route, and clinical uses.
Centrally acting muscle relaxants can be further divided into spasmolytic and antispasmodic drugs. Spasmolytic...
Centrally acting muscle relaxants can be further divided into spasmolytic and antispasmodic drugs. Spasmolytic...
3.7K
Centrally Acting Muscle Relaxants: Therapeutic Uses
846
Centrally acting muscle relaxants reduce muscle tone and tension by interfering with the postsynaptic reflexes in the central nervous system.
Centrally acting drugs are classified into spasmolytic and antispasmodic drugs. Spasmolytic drugs such as baclofen, diazepam, and tizanidine inhibit spinal motor neurons and decrease muscle tone. Spasmolytic drugs are administered for severe and chronic spasms due to multiple sclerosis, cerebral palsy, stroke, and spinal cord and muscle injuries. However,...
Centrally acting drugs are classified into spasmolytic and antispasmodic drugs. Spasmolytic drugs such as baclofen, diazepam, and tizanidine inhibit spinal motor neurons and decrease muscle tone. Spasmolytic drugs are administered for severe and chronic spasms due to multiple sclerosis, cerebral palsy, stroke, and spinal cord and muscle injuries. However,...
846


